Work Here?
Work Here?
Work Here?
Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on targeted protein degradation, which can lead to more precise therapies. The company's goal is to create next-generation medicines that meet unmet medical needs, supported by partnerships with organizations like Sanofi to enhance their research and development efforts.
Company Stage
IPO
Employees
201-500
Industries
Hardware, Biotechnology
Total Funding
$879M
Headquarters
N/A
Founded
2016
Find jobs on Simplify and start your career today